Parnassus Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.2M	Buy	48,991 +4,431	+10%	+$1.51M	0.05%	106
2025 Q4	$17.7M	Buy	44,560 +7,546	+20%	+$3.34M	0.05%	114
2025 Q3	$16.9M	Sell	37,014 -398	-1%	-$162K	0.04%	119
2025 Q2	$12.2M	Buy	+37,412	New	+$10.4M	0.03%	122
2024 Q2	–	Sell	-38,748	Closed	-$5.79M	–	130
2024 Q1	$5.79M	Hold	38,748	–	–	0.01%	120
2023 Q4	$7.42M	Hold	38,748	–	–	0.02%	114
2023 Q3	$6.86M	Buy	+38,748	New	+$7.39M	0.02%	119
2022 Q4	–	Sell	-25,970	Closed	-$5.2M	–	138
2022 Q3	$5.2M	Sell	25,970 -32,068	-55%	-$6.12M	0.01%	126
2022 Q2	$8.46M	Sell	58,038 -19,549	-25%	-$2.77M	0.02%	124
2022 Q1	$12.7M	Hold	77,587	–	–	0.03%	128
2021 Q4	$13.2M	Hold	77,587	–	–	0.03%	121
2021 Q3	$14.6M	Hold	77,587	–	–	0.03%	119
2021 Q2	$13.2M	Hold	77,587	–	–	0.03%	119
2021 Q1	$11M	Hold	77,587	–	–	0.03%	121
2020 Q4	$10.1M	Buy	+77,587	New	+$10.4M	0.03%	110